Results 61 to 70 of about 10,216 (173)
Apparent Recurrence of Hyperparathyroidism following Quadruple Parathyroidectomy
Case Reports in Endocrinology, 2013 Recurrent hyperparathyroidism can occur following quadruple parathyroidectomy and during radical parathyroidectomy and so that future hypoparathyroidism is avoided autotransplantation of parathyroid tissue is often preformed. Herein, I describe a patient
David S. H. Bell
doaj +1 more source
Вестник хирургии имени И.И. Грекова, 2018 The efficacy of total parathyroidectomy was shown in 18 patients with renal hyperparathyroidism after 6-12 years period after operation. The authors accepted the total parathyroidectomy as a reasonable way for treatment of secondary hyperthyroidism in ...
T. D. Evmenova, L. G. Lyamina
doaj +1 more source
Failed Parathyroidectomy: The road ahead
Indian Journal of Endocrinology and Metabolism, 2012 Persistent hyperparathyroidism due to failed parathyroidectomy is an uncommon but challenging problem as re-operation carries higher complication and failure rates.
Amit Agarwal, Roma Pradhan
doaj +1 more source
Thyroid Ablation: Minimally Invasive to Added Complexity
World Journal of Surgery, Volume 50, Issue 7, Page 1735-1736, July 2026.
Kelvin Memeh, Priya H. Dedhia
wiley +1 more source
Acute Calcium Pyrophosphate Arthritis after Parathyroidectomy
Türk Osteoporoz Dergisi, 2017 Hypocalcemia after parathyroidectomy is a well-known metabolic sequela, but rare conditions such as acute calcium pyrophosphate (CPP) arthritis can be observed.
Alper Uçkun +3 more
doaj +1 more source
Inadvertent Parathyroidectomy [PDF]
Proceedings of the Royal Society of Medicine, 1961 R S, MURLEY, P M, PETERS
openaire +2 more sources
Parathyroidectomy in the calcimimetic era [PDF]
Nephrology, 2005 SUMMARY: With the introduction of the calcimimetic cinacalcet HCl, some patients who would previously have undergone parathyroidectomy are likely to remain on medical therapy. Data is available on complication rates and some important outcome measures of parathyroidectomy, but the efficacy of calcimimetics to influence patient‐based endpoints such as ...
openaire +2 more sources
Endocrine Connections, 2019 Primary hyperparathyroidism is the most frequent manifestation of multiple endocrine neoplasia type 1 (MEN1) syndrome. Bone and renal complications are common.
Cristina Lamas +13 more
doaj +1 more source
Kidney International ReportsIntroduction: Etelcalcetide is an i.v. calcimimetic agent, effectively reducing parathyroid hormone levels in patients on maintenance hemodialysis (HD).
Philippe Delaey +26 more
doaj +1 more source